comparator sourcing

The numbers of clinical trials that compare two active drugs, rather than testing a new drug against a placebo, are increasing. Comparator trials are chosen for two main reasons. Firstly, there m...

Steve Jacobs, Chair of the Global Clinical Suppliers Group and President of Global BioPharm Solutions, joins Helen Winsor from Pharma IQ, to discuss how to go about creating the best sponsor/vendor...

Increasing emphasis on the comparative effectiveness of pharmaceutical treatments has in recent years translated into a growing expectation for developers to prove the relative benefits of their new...

As the number of comparator trials continues to increase, there is a growing need for fast, effective sourcing of high-quality comparator products. For many firms, it has become a necessity, with...

One of the main challenges facing comparator professionals is ensuring a consistent supply, as well as reducing cost, and these were recently addressed by Andrea Chopek, writing for Contract Pharma....

Comparator effectiveness studies are growing in prominence within the pharmaceutical industry. This is due to an increasing onus on drug developers to carry out comparator effectiveness st...

With globalisation complicating the delivery of clinical trials, having a truly international sourcing company has become essential. Robert Donnell, head of business development at Durbin, talks a...

Claire Willsher, Manager for Analytical Preformulation at LifeCycle Pharma, joins Pharma IQ to discuss Comparator Studies. Pharma IQ: Can you describe a typical study design when using comparator...

Comparator sourcing is one of the leading difficulties in clinical trial supply today with those involved concerned about availability, limiting costs, reliability and shelf life. To further underst...